International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

MOEX:GEMA Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	158.39	151.22	125.78	98.17	129.17
Depreciation & Amortization	-	13.61	11.24	6.86	4.14
Other Amortization	-	0.09	-	-	-
Other Operating Activities	51.52	82.69	86.76	136.07	111.19
Operating Cash Flow	209.91	247.6	223.77	241.11	244.51
Operating Cash Flow Growth	-15.22%	10.65%	-7.19%	-1.39%	81.49%
Capital Expenditures	-5.35	-10.59	-14.18	-9.27	-4.68
Investment in Securities	-	-0.49	5.5	-99	-506.4
Other Investing Activities	14.6	21.94	6.54	0.89	32.19
Investing Cash Flow	-218.06	-6.53	4.84	-252.87	-77.52
Long-Term Debt Issued	-	-	-	200	-
Total Debt Issued	-	-	-	200	-
Long-Term Debt Repaid	-3.52	-	-	-1.87	-
Net Debt Issued (Repaid)	-3.52	-	-	198.13	-
Common Dividends Paid	-111.42	-153.4	-122.74	-141.06	-150.19
Other Financing Activities	-7.93	-6.88	14.25	-5	-6.02
Financing Cash Flow	-122.87	-160.28	-108.49	52.07	-156.21
Foreign Exchange Rate Adjustments	-	0.03	-0.03	-0.3	-0.01
Net Cash Flow	-131.02	80.83	120.09	40.01	10.76
Free Cash Flow	204.55	237.02	209.59	231.83	239.82
Free Cash Flow Growth	-13.70%	13.08%	-9.59%	-3.33%	81.33%
Free Cash Flow Margin	54.30%	67.99%	73.93%	91.03%	90.20%
Free Cash Flow Per Share	13.70	15.88	14.04	15.53	16.06
Cash Interest Paid	-	31.57	31.57	3.74	3.52
Levered Free Cash Flow	139.57	108.53	99.84	557.78	-334.44
Unlevered Free Cash Flow	161.15	130.14	120.82	568.79	-332.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.